“Commentary on ‘Preventive Percutaneous Coronary Intervention Versus Optimal Medical Therapy Alone for the Treatment of Vulnerable Atherosclerotic Coronary Plaques (PREVENT): A Multicenter, Open-Label, Randomized Controlled trial’”. 2024. Bleeding, Thrombosis and Vascular Biology 3 (2). https://doi.org/10.4081/btvb.2024.141.